T. Rowe Price Associates’s Lucira Health, Inc. Common Stock LHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-17,400
| Closed | -$32K | – | 3065 |
|
|
2022
Q2 | $32K | Hold |
17,400
| – | – | ﹤0.01% | 2900 |
|
|
2022
Q1 | $62K | Hold |
17,400
| – | – | ﹤0.01% | 2898 |
|
|
2021
Q4 | $150K | Buy |
17,400
+7,200
| +71% | +$62.1K | ﹤0.01% | 2809 |
|
|
2021
Q3 | $78K | Sell |
10,200
-4,600
| -31% | -$35.2K | ﹤0.01% | 2868 |
|
|
2021
Q2 | $98K | Buy |
+14,800
| New | +$98K | ﹤0.01% | 2844 |
|